Atebimetinib + GnP as a First Line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma
for Pancreatic Cancer
Drug: Atebimetinib
12 locations incl. Phoenix
Sponsor: Immuneering Corporation
Sex: All·Age: 18+
Code: NCT07562152·Phase 3·Recruiting